Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

about

Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors).

P2860

Q47427825-25129198-448D-48A9-8E8F-8163B386C46E

P2860

Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

Item

http://www.wikidata.org/entity/Q39128628

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

@en

Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

@nl

type

Item

label

Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

@en

Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

@nl

prefLabel

Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

@en

Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

@nl

P1476

Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

@en

P2093

David Tweedie

http://www.w3.org/2001/XMLSchema#string

Hanuma Kumar Karnati

http://www.w3.org/2001/XMLSchema#string

Manas Kumar Panigrahi

http://www.w3.org/2001/XMLSchema#string

Nigel H Greig

http://www.w3.org/2001/XMLSchema#string

Yazhou Li

http://www.w3.org/2001/XMLSchema#string

P2860

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

Mediation of the DCC apoptotic signal by DIP13 alpha

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

Sialic acid modification of adiponectin is not required for multimerization or secretion but determines half-life in circulation

APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment

APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function

T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin

Modes of resistance to anti-angiogenic therapy

Cross-Talk between Adiponectin and IGF-IR in Breast Cancer

Adiponectin, driver or passenger on the road to insulin sensitivity?

P304

4170-4179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1381612823666170208123553

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28183249

http://www.w3.org/2001/XMLSchema#string

P932

5831726

http://www.w3.org/2001/XMLSchema#string

Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

about

P2860

P2860

Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932